MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-02-17 for EDAP ABLATHERM INTEGRATED IMAGING manufactured by Edap Tms France Sa.
[71247169]
A (b)(6) man underwent prostate hemiablation with edap ablatherm for gleason 7 prostate cancer in (b)(6) 2016. Patient experienced 3 episodes of urinary retention. Had to be hospitalized on two occasions. First time for clot evaluation from hematuria.
Patient Sequence No: 1, Text Type: D, B5
Report Number | MW5068716 |
MDR Report Key | 6442255 |
Date Received | 2017-02-17 |
Date of Report | 2017-02-06 |
Date of Event | 2016-12-15 |
Date Added to Maude | 2017-03-29 |
Event Key | 0 |
Report Source Code | Voluntary report |
Manufacturer Link | N |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 0 |
Brand Name | EDAP ABLATHERM INTEGRATED IMAGING |
Generic Name | EDAP ABLATHERM INTEGRATED IMAGING |
Product Code | PLP |
Date Received | 2017-02-17 |
Operator | NO INFORMATION |
Device Availability | * |
Device Eval'ed by Mfgr | I |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | EDAP TMS FRANCE SA |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Hospitalization | 2017-02-17 |